Help advance influenza research
Could you be part of the next vaccine breakthrough?
Want to help your community by advancing influenza research and potentially be compensated? See if you are eligible to join a clinical study. Vaccination is the primary method for preventing influenza and its potentially severe complications. Efficacy of the conventional influenza vaccines in the adult population is demonstrated to be high.
50 and above
- Influenza, or the flu, is a threat to global health worldwide with an estimated 1 billion cases every year
- Seasonal flu vaccines are approved for use in most populations, but leave room for improvement, as they typically provide 40 percent to 60 percent protection against circulating flu strains
- Seasonal flu is a respiratory infection caused by the flu virus
- Flu results in an estimated 1 billion cases every year, including approximately 5 million cases of severe illness and 290,000 to up to 650,000 deaths worldwide
- Flu spreads easily and can lead to serious complications for people with weakened immune systems, certain chronic medical conditions, older people, young children, and pregnant women
More Information About Flu and Influenza
It is estimated that the global disease burden from influenza includes up to a billion infections, 3–5 million cases of severe disease, and 290,000–650,000 deaths annually. 1 Adults 65 years of age or older are particularly vulnerable to the complications resulting from influenza infections with higher rates of influenza‐associated complications and hospitalizations than younger people. 2 , 3 , 4 Older adults make up the majority of influenza related deaths, with up to 90% of deaths occurring in this age group. 5
This research study is enrolling people who:
Are you 50 years or older?
Are generally healthy or have stable chronic conditions
Are not pregnant
Have not had a COVID-19 or any other vaccine in the last month